Boule Diagnostics AB (publ) (STO:BOUL)
Sweden · Delayed Price · Currency is SEK 3.860
-0.030 (-0.77%)
Jul 6, 2026, 5:29 PM CET
Boule Diagnostics AB Company Description
Boule Diagnostics AB (publ) develops, manufactures, and markets instruments and consumable products for blood diagnostics in the United States of America, Asia, Eastern Europe, Latin America, Western Europe, Africa, and the Middle East.
It operates through Diagnostics and OEM Clinical Diagnostic Solutions. The company provides hematology analyzers, reagents, controls, and calibrators, under the Swelab, and Medonic brands; and veterinary hematology and clinical chemistry analyzer systems, as well as reagents and panels under the Exigo brand.
It serves small and medium-sized hospitals, clinics, laboratories, and veterinary clinics, and other diagnostics firms.
The company was founded in 1956 and is headquartered in Spånga, Sweden.
Boule Diagnostics AB (publ)
| Country | Sweden |
| Founded | 1956 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 200 |
| CEO | Johan Folkunger |
Contact Details
Address: Fagerstagatan 7 Spånga, 163 53 Sweden | |
| Phone | 46 87 44 77 00 |
| Website | boule.com |
Stock Details
| Ticker Symbol | BOUL |
| Exchange | Nasdaq Stockholm |
| Fiscal Year | January - December |
| Reporting Currency | SEK |
| ISIN Number | SE0011231158 |
| SIC Code | 2835 |
Key Executives
| Name | Position |
|---|---|
| Simonetta Tumbiolo | Interim Chief Executive Officer and Chief Commercial Officer of Diagnostic |